On May 16, the Centers for Medicare & Medicaid Services(CMS) released their final rule titled “Modernizing Part D and MedicareAdvantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” Highlightsfrom this final rule include:
The ACCC policy team will continue to analyze this rule andprovide a more detailed analysis at a later date.
Readthe CMS final rule here.
Posted 5/17/2019

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
